Sharda Cropchem Ltd Upgraded to Strong Buy on Robust Fundamentals and Technicals

Technical Trends Signal Bullish Momentum

The primary catalyst for the rating upgrade stems from a marked improvement in Sharda Cropchem’s technical profile. The technical grade shifted from mildly bullish to bullish, supported by a confluence of positive signals across multiple timeframes. On the weekly and monthly charts, the Moving Average Convergence Divergence (MACD) indicator remains bullish, signalling sustained upward momentum. Complementing this, Bollinger Bands on both weekly and monthly scales also indicate bullish trends, suggesting the stock price is trading near the upper band with potential for further gains.

Daily moving averages reinforce this positive outlook, showing consistent upward trajectories. Although the Know Sure Thing (KST) indicator remains mildly bearish on weekly and monthly frames, the Dow Theory readings are mildly bullish, indicating a nuanced but overall positive technical environment. The Relative Strength Index (RSI) and On-Balance Volume (OBV) currently show no definitive signals, but the prevailing technical momentum has been sufficient to upgrade the technical grade decisively.

On 12 May 2026, Sharda Cropchem’s stock price closed at ₹1,159.05, up 3.39% from the previous close of ₹1,121.05, with intraday highs reaching ₹1,184.45. The stock remains comfortably above its 52-week low of ₹547.70 and is approaching its 52-week high of ₹1,297.80, underscoring the strength of the recent rally.

Valuation Adjusted to Fair from Attractive

While the technical outlook has improved, the valuation grade for Sharda Cropchem has been downgraded from attractive to fair. This adjustment reflects the stock’s premium pricing relative to its historical and peer benchmarks. The company currently trades at a price-to-earnings (PE) ratio of 18.42, which is moderate but higher than some peers in the Pesticides & Agrochemicals sector.

Other valuation multiples include an EV to EBITDA ratio of 10.81 and a price-to-book value of 3.89, indicating that the stock is priced at a premium but not excessively so. The PEG ratio stands at a notably low 0.14, signalling that earnings growth is outpacing the price increase, which is a positive sign for investors seeking growth at a reasonable price.

Comparatively, Bayer CropScience is rated as expensive with a PE of 30.09 and EV to EBITDA of 23.25, while Dhanuka Agritech is considered very attractive with a PE of 16.24 and EV to EBITDA of 11.45. Sharda Cropchem’s fair valuation grade reflects a balanced view acknowledging both its growth prospects and current market pricing.

Strong Financial Trends Underpin Confidence

Sharda Cropchem’s financial performance has been a key driver behind the upgrade. The company reported very positive results for Q3 FY25-26, with net sales growing at an annualised rate of 18.17% and operating profit increasing by 19.11%. Net profit growth has been particularly impressive, surging by 365.99% in the quarter, with the company declaring positive results for seven consecutive quarters.

For the nine months ended December 2025, the company posted a PAT of ₹362.21 crores, reflecting a growth of 259.30%, while PBT excluding other income stood at ₹157.32 crores, up 247.21%. Net sales for the same period reached ₹3,202.68 crores, growing 28.55% year-on-year. These robust financial metrics highlight the company’s operational efficiency and strong market positioning.

Return on Capital Employed (ROCE) is healthy at 24.83%, and Return on Equity (ROE) stands at 16.89%, underscoring effective capital utilisation and shareholder value creation. The company is net-debt free, further strengthening its financial stability and capacity to invest in growth initiatives.

Quality Assessment and Market Position

Sharda Cropchem’s quality grade remains high, supported by consistent earnings growth, strong return ratios, and a clean balance sheet. The company is ranked among the top 1% of all stocks rated by MarketsMojo, placing 22nd among small-cap stocks and 38th across the entire market universe of over 4,000 stocks. This elite ranking reflects its superior fundamentals and market performance.

Over the past year, the stock has delivered a remarkable return of 120.44%, vastly outperforming the Sensex, which declined by 4.33% over the same period. Longer-term returns are equally impressive, with a 5-year return of 251.17% compared to the Sensex’s 54.62%, and a 10-year return of 311.96% versus the Sensex’s 196.97%. This sustained outperformance highlights the company’s ability to generate shareholder wealth consistently.

Technical and Market Outlook

The upgrade to Strong Buy is also supported by the stock’s technical resilience and market momentum. The stock’s recent weekly return of 11.58% contrasts sharply with the Sensex’s decline of 1.62%, while the one-month return of 9.58% similarly outpaces the Sensex’s negative 1.98%. Year-to-date, Sharda Cropchem has gained 32.57%, whereas the Sensex has fallen 10.80%, signalling strong investor confidence.

These gains are underpinned by the company’s ability to maintain positive earnings momentum and robust operational metrics, which have attracted sustained buying interest. The stock’s technical indicators suggest further upside potential, making it an attractive proposition for investors seeking growth in the pesticides and agrochemicals sector.

Conclusion: A Compelling Investment Proposition

Sharda Cropchem Ltd’s upgrade to a Strong Buy rating by MarketsMojo reflects a comprehensive improvement across four critical parameters: technicals, valuation, financial trends, and quality. The bullish technical signals, combined with strong financial results and a fair valuation, position the stock favourably for continued growth. Its market-beating returns over multiple time horizons further reinforce its appeal as a small-cap investment.

Investors looking for exposure to the pesticides and agrochemicals sector would do well to consider Sharda Cropchem’s robust fundamentals and positive outlook as part of a diversified portfolio strategy.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →